These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15949595)

  • 1. Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure.
    Mac Manus MP; Hicks RJ; Matthews JP; Wirth A; Rischin D; Ball DL
    Lung Cancer; 2005 Jul; 49(1):95-108. PubMed ID: 15949595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment.
    Mac Manus MP; Hicks RJ; Ball DL; Kalff V; Matthews JP; Salminen E; Khaw P; Wirth A; Rischin D; McKenzie A
    Cancer; 2001 Aug; 92(4):886-95. PubMed ID: 11550162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.
    Kong FM; Frey KA; Quint LE; Ten Haken RK; Hayman JA; Kessler M; Chetty IJ; Normolle D; Eisbruch A; Lawrence TS
    J Clin Oncol; 2007 Jul; 25(21):3116-23. PubMed ID: 17634490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What
    Turgeon GA; Iravani A; Akhurst T; Beaulieu A; Callahan JW; Bressel M; Cole AJ; Everitt SJ; Siva S; Hicks RJ; Ball DL; Mac Manus MP
    J Nucl Med; 2019 Mar; 60(3):328-334. PubMed ID: 30030343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?
    Dhull VS; Sharma P; Sharma DN; Maharjan S; Suman Kc S; Patel C; Bal C; Kumar R
    Int J Gynecol Cancer; 2014 Feb; 24(2):312-20. PubMed ID: 24407578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
    Skougaard K; Nielsen D; Jensen BV; Hendel HW
    J Nucl Med; 2013 Jul; 54(7):1026-31. PubMed ID: 23572497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.
    Everitt S; Hicks RJ; Ball D; Kron T; Schneider-Kolsky M; Walter T; Binns D; Mac Manus M
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1098-104. PubMed ID: 19386444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study.
    van Loon J; Grutters J; Wanders R; Boersma L; Oellers M; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Fatah SA; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
    Eur J Cancer; 2009 Mar; 45(4):588-95. PubMed ID: 19046631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.
    Kim MK; Ryu JS; Kim SB; Ahn JH; Kim SY; Park SI; Kim YH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
    Eur J Cancer; 2007 Jun; 43(9):1385-91. PubMed ID: 17512192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?
    Abramyuk A; Tokalov S; Zöphel K; Koch A; Szluha Lazanyi K; Gillham C; Herrmann T; Abolmaali N
    Radiother Oncol; 2009 Jun; 91(3):399-404. PubMed ID: 19168248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib.
    Tiseo M; Ippolito M; Scarlattei M; Spadaro P; Cosentino S; Latteri F; Ruffini L; Bartolotti M; Bortesi B; Fumarola C; Caffarra C; Cavazzoni A; Alfieri RR; Petronini PG; Bordonaro R; Bruzzi P; Ardizzoni A; Soto Parra HJ
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):299-307. PubMed ID: 24258456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.
    Campeau MP; Herschtal A; Wheeler G; Mac Manus M; Wirth A; Michael M; Hogg A; Drummond E; Ball D
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1371-5. PubMed ID: 19250769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study.
    De Ruysscher D; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Utama I; Simons J; Dohmen J; Rhami A; Buell U; Thimister P; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Minken A; Bentzen SM; Lambin P
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):988-94. PubMed ID: 15989999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer.
    Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):185-90. PubMed ID: 22014958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
    Mac Manus MP; Ding Z; Hogg A; Herschtal A; Binns D; Ball DL; Hicks RJ
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1365-71. PubMed ID: 20675076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
    Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ
    J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.
    MacManus MP; Hicks RJ; Matthews JP; Hogg A; McKenzie AF; Wirth A; Ware RE; Ball DL
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):287-93. PubMed ID: 11380213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of
    Tang S; Zhang Y; Li Y; Zhang Y; Xu Y; Ding H; Chen Y; Ren P; Ye H; Fu S; Lin S
    Front Immunol; 2023; 14():1034416. PubMed ID: 36860861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.
    Hoopes DJ; Tann M; Fletcher JW; Forquer JA; Lin PF; Lo SS; Timmerman RD; McGarry RC
    Lung Cancer; 2007 May; 56(2):229-34. PubMed ID: 17353064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.